Conversely, elevated expression of METTL3 was determined in AML, bladder cancer, gastric cancer, and liver cancer, where it had been suggested to function as an oncogene, suggesting critical mechanisms for tumor progression [129,130]. Here, METTL3 is linked to urinary bladder carcinoma.